APA (7th ed.) Citation

Yee, K. L., DiBenedetto, A., Fan, L., Khalilieh, S., Triantafyllou, I., Vallee, M., . . . Iwamoto, M. (2020). Comparative Bioavailability of Oral Granule Formulations of the HIV Antiretroviral Drugs Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate. AAPS PharmSciTech: An Official Journal of the American Association of Pharmaceutical Scientists, 21(3), . https://doi.org/10.1208/s12249-020-1630-6

Chicago Style (17th ed.) Citation

Yee, Ka Lai, Adrienne DiBenedetto, Li Fan, Sauzanne Khalilieh, Ilias Triantafyllou, Marie-Helene Vallee, Paul Fackler, S. Aubrey Stoch, and Marian Iwamoto. "Comparative Bioavailability of Oral Granule Formulations of the HIV Antiretroviral Drugs Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate." AAPS PharmSciTech: An Official Journal of the American Association of Pharmaceutical Scientists 21, no. 3 (2020). https://doi.org/10.1208/s12249-020-1630-6.

MLA (9th ed.) Citation

Yee, Ka Lai, et al. "Comparative Bioavailability of Oral Granule Formulations of the HIV Antiretroviral Drugs Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate." AAPS PharmSciTech: An Official Journal of the American Association of Pharmaceutical Scientists, vol. 21, no. 3, 2020, https://doi.org/10.1208/s12249-020-1630-6.